November 2024, Cambridge, MA – Seasoned drug delivery executive, Steven Kaufman, to join Portal Instruments as their Chief Commercial Officer. Prior to joining Portal Instruments in November 2024, Steven held executive positions at Stevanato Group, Bespak and SHL Medical.
November, 2024 Cambridge, MA – Portal Instruments is pleased to announce that Steven Kaufman will be joining Portal Instruments as their interim Chief Commercial Officer.
Steven is a recognized leader in the device industry, having held numerous leadership roles related to Business Development, Product Management, Marketing and Strategy. Prior to joining Portal Instruments in November 2024, Steven held executive positions at Stevanato Group, Bespak and SHL Medical.
Patrick Anquetil, CEO, welcomed Steven, noting Steven's broad expertise in the area of self-injection devices and his proven track-record taking devices from design, development, manufacture, final assembly to clinical and then commercial launch in Europe, North America and APAC. "Steven's expertise in drug delivery will be a strong asset to Portal Instruments as we continue to move towards commercialization."
March 23, 2021 - Cambridge, MA The Sumaira Foundation for NMO (TSF) and Portal Instruments are pleased to announce their partnership. Portal Instruments and TSF share a joint vision of creating a better experience and improved treatment options for patients diagnosed with NMOSD.
Today Portal Instruments announced the signing of a multi-million-dollar development agreement with a leading biotech company to advance its large-volume, reusable autoinjector, PRIME NEXUS™, toward clinical readiness in Q1 2027.
April 2021 - In the US, approximately 12% of women age 15 to 44 have trouble getting pregnant or carrying a pregnancy to term.¹ To honor National Infertility Week we sat down with Myra, an infertility nurse to talk about the hardships and joys associated with infertility treatment.
Please fill out the details below and we will get back to you shortly.